Danish medical company Coloplast delivers strong full-year results and expects high future growth.
31 oct. 2014 06h11 HE
|
Coloplast A/S
Revenue was up by 9% to DKK 12,428m for the 2013/14 financial year, with the EBIT margin before special items at 33%, versus 32% last year. EBIT before special items increased by 13% to reach DKK...
Årsrapport 2013/14 og Corporate Responsibility Report
30 oct. 2014 06h55 HE
|
Coloplast A/S
Årsrapport 2013/14 og Corporate Responsibility Report
Se vedlagte PDFer....
Annual report 2013/14 and Corporate Responsibility Report
30 oct. 2014 06h55 HE
|
Coloplast A/S
Annual report 2013/14 and Corporate Responsibility Report
See enclosed PDF's....
Coloplast delivers strong full-year results and expects high future growth
30 oct. 2014 06h36 HE
|
Coloplast A/S
Revenue was up by 9% to DKK 12,428m for the 2013/14 financial year, with the EBIT margin before special items at 33%, versus 32% last year. EBIT before special items increased by 13% to reach DKK...
Coloplast leverede stærkt årsresultat og forventer fortsat høj vækst
30 oct. 2014 06h36 HE
|
Coloplast A/S
For regnskabsåret 2013/2014 steg omsætningen med 9% til 12.428 mio. kr., og overskudsgraden (EBIT-marginen) før særlige poster blev 33% mod 32% sidste år. Driftsresultatet (EBIT) før særlige poster...
Announcement of full-year financial results 2013/14
30 oct. 2014 06h35 HE
|
Coloplast A/S
Announcement of full-year financial results 2013/14
See enclosed PDF.
...
Årsregnskabsmeddelelse 2013/14
30 oct. 2014 06h35 HE
|
Coloplast A/S
Årsregnskabsmeddelelse 2013/14.
Se PDF....